Nationwide Laboratories recalls
Nationwide Laboratories appears in 4 official U.S. recall notices indexed by RecallRadar, most recently on 2016-12-07.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 4 |
|---|---|
| Published | 2016-12-07 |
| By agency | FDA Drug (4) |
| By classification | Class II (4) |
| By status | terminated (4) |
| Distribution named in notices | US |
Recalls
- Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18)
FDA Drug · Class II · 2016-12-07 · Nationwide Laboratories
Reason: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures. - Salsalate Tablets, USP, 750 mg, packaged in a) 100 count bottles (NDC 42937-704-10)
FDA Drug · Class II · 2016-12-07 · Nationwide Laboratories
Reason: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures. - Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New…
FDA Drug · Class II · 2016-12-07 · Nationwide Laboratories
Reason: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures. - Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New…
FDA Drug · Class II · 2016-12-07 · Nationwide Laboratories
Reason: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.